Where to purchase Trastuzumab injection (subcutaneous injection) (Herceptin Hylecta)
Trastuzumab injection (subcutaneous ) (Herceptin Hylecta) will select patients for treatment based on trastuzumab trials approved by the U.S. Food and Drug Administration (FDA). There are two approved uses in adults with metastatic breast cancer, including paclitaxel, which is approved in combination with the chemotherapy drug paclitaxel for the first-line treatment of epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer; and alone, it is approved for the treatment of patients with HER2-positive breast cancer who have received one or more courses of chemotherapy for metastatic disease.

Trastuzumab injection is approved to treat adults with early-stage breast cancer that is human epidermal growth factor receptor 2-positive (HER2+) and has spread to lymph nodes, or adults with early-stage breast cancer that is HER2-positive but has not spread to lymph nodes. If it has not spread to lymph nodes, the cancer needs to be estrogen receptor/progesterone receptor (ER/PR) negative or have a high-risk signature. As part of a treatment course that includes the chemotherapy drugs doxorubicin, cyclophosphamide, and paclitaxel or docetaxel. This course of treatment is called "AC TH"; it includes the chemotherapy drugs docetaxel and carboplatin. This course of treatment is called "TCH"; used alone after treatment with a variety of other therapies, including anthracycline (doxorubicin)-based therapy (a type of chemotherapy).
It is understood that the original drug of trastuzumab injection (subcutaneous injection) has been launched in China, but the specific price and other relevant information are not yet clear. Because the drug has been on the market for a short time, it has not been included in the scope of medical insurance, and domestic purchase channels are still relatively difficult. At present, there are no generic drugs of Trastuzumab injection (subcutaneous injection) produced and marketed. For more information and specific prices of Trastuzumab injection (subcutaneous injection), please consult a medical consultant.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)